Timo Grimmer
About
Timo Grimmer is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience.
According to data from OpenAlex, Timo Grimmer has authored 158 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Psychiatry and Mental health, 84 papers in Physiology and 49 papers in Cognitive Neuroscience. Recurrent topics in Timo Grimmer's work include Dementia and Cognitive Impairment Research (94 papers), Alzheimer's disease research and treatments (81 papers) and Functional Brain Connectivity Studies (39 papers). Timo Grimmer is often cited by papers focused on Dementia and Cognitive Impairment Research (94 papers), Alzheimer's disease research and treatments (81 papers) and Functional Brain Connectivity Studies (39 papers). Timo Grimmer collaborates with scholars based in Germany, United Kingdom and United States. Timo Grimmer's co-authors include Alexander Drzezga, Alexander Kurz, Robert Perneczky, Hans Förstl, Christian Sorg, Janine Diehl‐Schmid, Janine Diehl, Markus J. Riemenschneider, Alexander Kurz and Stefan Wagenpfeil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.
In The Last Decade
Timo Grimmer
153 papers receiving 5.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Timo Grimmer Germany | 42 | 2.9k | 2.6k | 1.9k | 1.2k | 765 | 158 | 5.9k | ||
| Robert Perneczky Germany | 47 | 3.5k 1.2× | 3.1k 1.2× | 1.7k 0.9× | 1.0k 0.8× | 1.0k 1.3× | 200 | 7.2k | ||
| Ozioma C. Okonkwo United States | 54 | 3.8k 1.3× | 2.8k 1.1× | 2.0k 1.1× | 1.2k 1.0× | 909 1.2× | 229 | 9.1k | ||
| Merja Hallikainen Finland | 38 | 3.3k 1.1× | 2.7k 1.0× | 1.5k 0.8× | 816 0.7× | 1.0k 1.3× | 79 | 6.2k | ||
| Pierrick Bourgeat Australia | 37 | 3.4k 1.2× | 3.7k 1.4× | 1.6k 0.9× | 1.6k 1.3× | 1.1k 1.5× | 229 | 7.2k | ||
| Aaron P. Schultz United States | 50 | 3.6k 1.2× | 3.3k 1.2× | 3.0k 1.6× | 1.4k 1.1× | 972 1.3× | 157 | 7.0k | ||
| Kerryn E. Pike Australia | 24 | 3.2k 1.1× | 3.0k 1.1× | 1.6k 0.8× | 800 0.6× | 710 0.9× | 82 | 5.1k | ||
| Ronald Petersen United States | 31 | 3.1k 1.1× | 2.9k 1.1× | 1.6k 0.8× | 957 0.8× | 1.0k 1.3× | 67 | 6.4k | ||
| Greg Savage Australia | 35 | 3.0k 1.0× | 2.2k 0.8× | 2.1k 1.1× | 741 0.6× | 710 0.9× | 137 | 5.7k | ||
| Brian A. Gordon United States | 33 | 2.4k 0.8× | 2.6k 1.0× | 1.6k 0.8× | 785 0.6× | 780 1.0× | 159 | 5.2k | ||
| Adam Fleisher United States | 48 | 3.8k 1.3× | 3.9k 1.5× | 2.5k 1.3× | 1.6k 1.3× | 905 1.2× | 121 | 7.8k |
Countries citing papers authored by Timo Grimmer
Since
Specialization
Citations
This map shows the geographic impact of Timo Grimmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Grimmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Grimmer more than expected).
Fields of papers citing papers by Timo Grimmer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Timo Grimmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Grimmer. The network helps show where Timo Grimmer may publish in the future.
Co-authorship network of co-authors of Timo Grimmer
This figure shows the co-authorship network connecting the top 25 collaborators of Timo Grimmer. A scholar is included among the top collaborators of Timo Grimmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Grimmer. Timo Grimmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Manuilova, Ekaterina, et al.. (2025). Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer s & Dementia. 21(10). e70797–e70797.
2.
Mueller, Karsten, Nico Scherf, Timo Grimmer, et al.. (2025). Criminal Behavior in Frontotemporal Dementia: A Multimodal MRI Study. Human Brain Mapping. 46(11). e70308–e70308.
3.
Perneczky, Robert, Niels Hansen, Anna Hofmann, et al.. (2024). Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings. Methods in molecular biology. 2785. 3–14.
4.
Goldhardt, Oliver, Hans Förstl, Dennis M. Hedderich, et al.. (2023). Head‐to‐head comparison of CSF AD biomarker assays: fully‐automated high‐throughput platforms (ECLIA and CLEIA) vs ELISA. Alzheimer s & Dementia. 19(S24).
5.
Oeckl, Patrick, Sarah Anderl‐Straub, Christine A. F. Von Arnim, et al.. (2022). Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. Journal of Neurology Neurosurgery & Psychiatry. 93(6). 659–667.
6.
Yakushev, Igor, Min Wang, Alexandre Savio, et al.. (2021). Mapping covariance in brain FDG uptake to structural connectivity. European Journal of Nuclear Medicine and Molecular Imaging. 49(4). 1288–1297.
7.
Ortner, Marion, Christine Hauser, Christoph Schmaderer, et al.. (2019). <p>Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography</p>. Neuropsychiatric Disease and Treatment. Volume 15. 3487–3499.
8.
Altomare, Daniele, Clarissa Ferrari, Anna Caroli, et al.. (2019). Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology. 266(10). 2535–2545.
9.
Ortner, Marion, Oliver Goldhardt, Janine Diehl‐Schmid, et al.. (2019). Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease. BMC Neurology. 19(1). 264–264.
10.
Kotliar, Konstantin, Christine Hauser, Marion Ortner, et al.. (2018). Does internal microstructure of retinal arteries change in Alzheimer disease. Investigative Ophthalmology & Visual Science. 59(9). 1583–1583.
11.
Kotliar, Konstantin, et al.. (2017). Dynamic retinal arterial and venous oscillations are changed in Alzheimer’s disease. Investigative Ophthalmology & Visual Science. 58(8). 1256–1256.
12.
Franzmeier, Nicolai, Jens Göttler, Timo Grimmer, et al.. (2017). Resting-State Connectivity of the Left Frontal Cortex to the Default Mode and Dorsal Attention Network Supports Reserve in Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 9. 264–264.
13.
Thompson, Garth J., Valentin Riedl, Timo Grimmer, et al.. (2016). The Whole-Brain “Global” Signal from Resting State fMRI as a Potential Biomarker of Quantitative State Changes in Glucose Metabolism. Brain Connectivity. 6(6). 435–447.
14.
Grimmer, Timo, Panagiotis Alexopoulos, Alexander Drzezga, et al.. (2015). Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. Journal of Nuclear Medicine. 57(2). 204–207.
15.
Pasquini, Lorenzo, Claudia Plant, Marion Ortner, et al.. (2014). Intrinsic Brain Activity of Cognitively Normal Older Persons Resembles More That of Patients Both with and at Risk for Alzheimer's Disease Than That of Healthy Younger Persons. Brain Connectivity. 4(5). 323–336.
16.
Sabri, Osama, Amane Tateno, Alexander Drzezga, et al.. (2011). Global phase 2b efficacy and safety trial of florbetaben for beta-amyloid brain positron emission tomography in Alzheimer's disease. UCL Discovery (University College London).
17.
Förster, Stefan, Timo Grimmer, Isabelle Miederer, et al.. (2011). Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay. Biological Psychiatry. 71(9). 792–797.
18.
Alexopoulos, Panagiotis, Christian Sorg, Annette Förschler, et al.. (2011). Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI. European Archives of Psychiatry and Clinical Neuroscience. 262(1). 69–77.
19.
Perneczky, Robert, Stefan Wagenpfeil, Katja Komossa, et al.. (2006). Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia Rating. American Journal of Geriatric Psychiatry. 14(2). 139–144.
20.
Drzezga, Alexander, Timo Grimmer, Stephan G. Nekolla, et al.. (2003). Differences of cerebral activation between healthy volunteers and patients with MCI and Alzheimer's disease during navigation in a virtual reality environment. An O15-water PET activation study.. mediaTUM (Technical University of Munich).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Robert Perneczky Breakdown of academic impact, for papers by Ozioma C. Okonkwo Breakdown of academic impact, for papers by Merja Hallikainen Breakdown of academic impact, for papers by Pierrick Bourgeat Breakdown of academic impact, for papers by Aaron P. Schultz Breakdown of academic impact, for papers by Kerryn E. Pike Breakdown of academic impact, for papers by Ronald Petersen Breakdown of academic impact, for papers by Greg Savage Breakdown of academic impact, for papers by Brian A. Gordon Breakdown of academic impact, for papers by Adam Fleisher